Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock

By AJ Fabino
September 8, 11:28 AM
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in its core HIV business and emerging hem

BAC

Read More
1 minute read
  • General
  • Health Care
  • Management
  • News

Billionaire Activist Investor Carl Icahn Shows Support For Illumina’s Newly Appointed CEO

By Vandana Singh
September 8, 10:04 AM
Activist investor Carl Icahn has thrown his support behind Illumina Inc's (NASDAQ: ILMN) new CEO, Jacob Thaysen, providing a sigh of relief for the company as it strives to recover from a contentious proxy battle with the 

ILMN

Read More
1 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • Large Cap
  • Markets
  • News

UK Authority Recommends Eli Lilly’s Famed Diabetes Drug Mounjaro As New Treatment Option For Type 2 Diabetes

By Vandana Singh
September 8, 9:38 AM
UK's National Institute for Health and Care Excellence (NICE) has endorsed Eli Lilly And Co's (NYSE: LLY) diabetes medication, Mounjaro (tirzepatide), indicating it as a viable option for patients grappling with poorly controlled type 2 diabetes. 

LLY

Read More
1 minute read
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?

By Vandana Singh
September 8, 9:18 AM
Biocept Inc (NASDAQ: BIOC) shares are trading higher after the company signed a non-exclusive licensing agreement for CNSide with Plus Therapeutics Inc (NASDAQ: PSTV), which expands the comprehensive labo

BIOC

Read More
6 minute read
  • Biotech
  • Equities
  • Exclusives
  • Health Care
  • News
  • Top Stories

EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With ‘Unique, But Pretty Simple’ Drug

By Shanthi Rexaline
September 8, 8:42 AM
Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.

CALT

Read More
1 minute read
  • Biotech
  • Contracts
  • Exclusives
  • General
  • Health Care
  • Market-Moving Exclusives
  • News
  • Penny Stocks

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers

By Vandana Singh
September 8, 6:30 AM
Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu

BIOC

Read More
1 minute read
  • General
  • Health Care
  • Legal
  • News

Philips Settles US Economic Loss Claims Over Sleep, Respiratory Device Recall

By Vandana Singh
September 7, 2:40 PM
Royal Philips (NYSE: PHG) has announced a significant development in its ongoing efforts to address concerns related to its 

PHG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Why Is Food & Animal Safety Solution Focused Neogen Stock Trading Lower Today?

By Vandana Singh
September 7, 2:36 PM
In an investor presentation at the Wells Fargo 2023 Healthcare Conference, Neogen Corporation (NASDAQ: NEOG) disclosed preliminary Q1 FY24 core revenue growth slightly 

NEOG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Health Care
  • Initiation
  • Markets
  • News
  • Penny Stocks
  • Price Target
  • Trading Ideas

Breaking The Hospital Chain: Analyst On How KORU’s Self-Administered Therapies Promise 20% CAGR Through 2026

By Vandana Singh
September 7, 2:27 PM
B.

KRMD

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Small Cap

Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?

By Vandana Singh
September 7, 2:12 PM
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called Degrader-Antib

NRIX

Posts pagination

Previous 1 … 168 169 170 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service